Shanghai Junshi Biosciences Breast Cancer Drug Obtains DRC From NMPA; Shares Jump 8%
Shanghai Junshi Biosciences Breast Cancer Drug Obtains DRC From NMPA; Shares Jump 8%
上海軍事生物科技公司的乳腺癌藥物獲得國家藥品監督管理局的藥品註冊證；股價上漲8%。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊